JP2023538645A5 - - Google Patents
Info
- Publication number
- JP2023538645A5 JP2023538645A5 JP2023512463A JP2023512463A JP2023538645A5 JP 2023538645 A5 JP2023538645 A5 JP 2023538645A5 JP 2023512463 A JP2023512463 A JP 2023512463A JP 2023512463 A JP2023512463 A JP 2023512463A JP 2023538645 A5 JP2023538645 A5 JP 2023538645A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- pharmaceutically acceptable
- alkyl group
- acceptable salt
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010845001.1 | 2020-08-20 | ||
| CN202010845001 | 2020-08-20 | ||
| CN202110373982.9 | 2021-04-07 | ||
| CN202110373982 | 2021-04-07 | ||
| PCT/CN2021/113815 WO2022037680A1 (zh) | 2020-08-20 | 2021-08-20 | 硼酸类化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538645A JP2023538645A (ja) | 2023-09-08 |
| JP2023538645A5 true JP2023538645A5 (https=) | 2024-08-28 |
Family
ID=80322587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512463A Pending JP2023538645A (ja) | 2020-08-20 | 2021-08-20 | ボロン酸化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12590108B2 (https=) |
| EP (1) | EP4201942A4 (https=) |
| JP (1) | JP2023538645A (https=) |
| KR (1) | KR20230104117A (https=) |
| CN (1) | CN116615431A (https=) |
| TW (1) | TW202214261A (https=) |
| WO (1) | WO2022037680A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023155869A1 (zh) * | 2022-02-18 | 2023-08-24 | 辉诺生物医药科技（杭州）有限公司 | 新的硼酸类化合物的晶型及其制备方法 |
| WO2025228222A1 (zh) * | 2024-04-30 | 2025-11-06 | 珠海联邦制药股份有限公司 | 硼酸类β-内酰胺酶抑制剂及其应用 |
| WO2026067428A1 (zh) * | 2024-09-30 | 2026-04-02 | 科睿迪(南京)医药科技有限公司 | 硼酸衍生物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100120715A1 (en) * | 2007-11-13 | 2010-05-13 | Burns Christopher J | Beta-lactamase inhibitors |
| US20100292185A1 (en) | 2009-05-12 | 2010-11-18 | Burns Christopher J | Beta-lactamase inhibitors |
| US9012491B2 (en) * | 2011-08-31 | 2015-04-21 | Rempex Pharmaceuticals, Inc. | Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
| CN105026407B (zh) * | 2012-12-07 | 2017-09-08 | 维纳拓尔斯制药公司 | β‑内酰胺酶抑制剂 |
| US20180051041A1 (en) * | 2015-03-17 | 2018-02-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| ES2894251T3 (es) * | 2016-06-30 | 2022-02-14 | Qpex Biopharma Inc | Derivados de ácido borónico y usos terapéuticos de los mismos |
-
2021
- 2021-08-20 JP JP2023512463A patent/JP2023538645A/ja active Pending
- 2021-08-20 TW TW110130943A patent/TW202214261A/zh unknown
- 2021-08-20 US US18/042,002 patent/US12590108B2/en active Active
- 2021-08-20 WO PCT/CN2021/113815 patent/WO2022037680A1/zh not_active Ceased
- 2021-08-20 CN CN202180055494.1A patent/CN116615431A/zh active Pending
- 2021-08-20 KR KR1020237008849A patent/KR20230104117A/ko active Pending
- 2021-08-20 EP EP21857768.2A patent/EP4201942A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538645A5 (https=) | ||
| RU2505532C2 (ru) | Соединение | |
| AU2014204046B2 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| JP2016505619A5 (https=) | ||
| US9642869B2 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| JP2009518317A5 (https=) | ||
| JP2022551185A5 (https=) | ||
| US5994340A (en) | Azetidinone derivatives as β-lactamase inhibitors | |
| CA2287219A1 (en) | 2-oxo-1-azetidine sulfonic acid derivatives as potent .beta.-lactamase inhibitors | |
| JP2012502974A5 (https=) | ||
| RU2011136537A (ru) | Кристаллическая форма (r)-3-(4-(2-метилтетразол-5-ил)пиридин-5-ил)-3-фторфенил)-5-гидроксиметил оксазолидин-2-он диводород фосфата | |
| JP2013544276A5 (https=) | ||
| RU2409562C2 (ru) | Новые производные 2-азетидинона в качестве ингибиторов всасывания холестерина для лечения гиперлипидемических состояний | |
| JP2013538802A5 (https=) | ||
| JP2013536188A5 (https=) | ||
| JP2010031025A5 (https=) | ||
| JP2013533253A5 (https=) | ||
| GB2124207A (en) | 1-sulfo-2-oxoazetidine derivatives | |
| JP2011529502A5 (https=) | ||
| JP2005539045A5 (https=) | ||
| MY148847A (en) | 5-hydroxymethyl-oxazolidin-2-one derivatives | |
| JP2015536974A5 (https=) | ||
| WO2008142094A4 (en) | Triazol compounds for treating biofilm formation | |
| WO2007096740A3 (en) | Novel cephalosporins | |
| RU2401267C2 (ru) | Замещенные производные бензохинолизина |